Kathmandu. Sopan Pharmaceuticals is going to launch an initial public offering (IPO) from March 9.
The company is issuing 42,90,000 units of shares worth Rs 42.90 crore i.e. 25% of the paid-up capital of Rs 1.71 billion. In the first phase, the company is issuing 4,29,000 units of shares to the Nepali migrant workers abroad.
In the second phase, 5% of the total offered shares to the general public will be issued to the mutual fund and 4% of the total offered shares will be reserved for the employees of the company while the remaining 3,474,900 units will be issued to the general public.
Applications can be place for minimum 10 units and maximum 11,000 units. They can apply till March 12. If the application is not received as demanded within this period, the application can be submitted till April 23.
The eligible applicants can apply for the post through ASBA approved banks and financial institutions and their designated branches and CDSC’s ‘My Shares’.
NMB Capital has been appointed as the issue manager for the IPO issuance.
